Loading...

Uralkali

OTCPK:URAY.Y
Snowflake Description

Moderate growth potential and slightly overvalued.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
URAY.Y
OTCPK
RUB112B
Market Cap
  1. Home
  2. US
  3. Materials
Company description

Public Joint Stock Company Uralkali, together with its subsidiaries, engages in the extraction, production, and sale of potash fertilizers. The last earnings update was 37 days ago. More info.


Add to Portfolio Compare Print
URAY.Y Share Price and Events
7 Day Returns
0%
OTCPK:URAY.Y
0.4%
US Chemicals
-0.3%
US Market
1 Year Returns
-
OTCPK:URAY.Y
-6.6%
US Chemicals
7%
US Market
URAY.Y Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Uralkali (URAY.Y) 0% 3.2% - - - -71.2%
US Chemicals 0.4% -1.6% 0.4% -6.6% 20.2% 16.8%
US Market -0.3% 2% 8.5% 7% 37.7% 46.8%
1 Year Return vs Industry and Market
  • No trading data on URAY.Y.
  • No trading data on URAY.Y.
Price Volatility
URAY.Y
Industry
5yr Volatility vs Market

URAY.Y Value

 Is Uralkali undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Uralkali to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Uralkali.

OTCPK:URAY.Y Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Extrapolated from most recent financials. See below
Discount Rate (Cost of Equity) See below 21.6%
Perpetual Growth Rate 10-Year US Government Bond Rate 2.7%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for OTCPK:URAY.Y
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year US Govt Bond Rate 2.7%
Equity Risk Premium S&P Global 9.4%
Chemicals Unlevered Beta Simply Wall St/ S&P Global 0.93
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.927 (1 + (1- 20%) (343.59%))
2.658
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
2
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 2.73% + (2 * 9.43%)
21.59%

Discounted Cash Flow Calculation for OTCPK:URAY.Y using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Uralkali is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

OTCPK:URAY.Y DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (USD, Millions) Source Present Value
Discounted (@ 21.59%)
2019 777.46 Est @ 2.31% 639.41
2020 796.37 Est @ 2.43% 538.66
2021 816.45 Est @ 2.52% 454.19
2022 837.55 Est @ 2.58% 383.19
2023 859.56 Est @ 2.63% 323.44
2024 882.41 Est @ 2.66% 273.08
2025 906.06 Est @ 2.68% 230.61
2026 930.48 Est @ 2.7% 194.77
2027 955.66 Est @ 2.71% 164.52
2028 981.58 Est @ 2.71% 138.98
Present value of next 10 years cash flows $3,340.85
OTCPK:URAY.Y DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2028 × (1 + g) ÷ (Discount Rate – g)
= $981.58 × (1 + 2.73%) ÷ (21.59% – 2.73%)
$5,346.65
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= $5,346.65 ÷ (1 + 21.59%)10
$757.01
OTCPK:URAY.Y Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= $3,340.85 + $757.01
$4,097.86
Equity Value per Share
(USD)
= Total value / Shares Outstanding
= $4,097.86 / 1,276.17
$43.5
OTCPK:URAY.Y Discount to Share Price
Calculation Result
Exchange Rate USD/RUB
(Reporting currency to currency of MISX:URKA)
64.049
Value per Share
(RUB)
= Value per Share in USD x Exchange Rate (USD/RUB)
= $3.21 x 64.049
RUB205.66
Non-primary Listing Adjustment Factor 1 share in OTCPK:URAY.Y represents 0.07381x of MISX:URKA
(This could be a different class, a depositary receipt, a different currency, or all of these things.)
0.07381x
Value per Share
(Listing Adjusted, USD)
= Value per Share (RUB) x Listing Adjustment Factor
= RUB 205.66 x 0.07381
$15.18
Value per share (USD) From above. $15.18
Current discount Discount to share price of $6.50
= -1 x ($6.50 - $15.18) / $15.18
57.2%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price Uralkali is available for.
Intrinsic value
>50%
Share price is $6.5 vs Future cash flow value of $15.18
Current Discount Checks
For Uralkali to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • Uralkali's share price is below the future cash flow value, and at a moderate discount (> 20%).
  • Uralkali's share price is below the future cash flow value, and at a substantial discount (> 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Uralkali's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Uralkali's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
OTCPK:URAY.Y PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-12-31) in USD $-0.08
MISX:URKA Share Price ** MISX (2019-04-12) in RUB RUB88.06
MISX:URKA Share Price converted to USD reporting currency Exchange rate (RUB/ USD) 0.016 $1.37
United States of America Chemicals Industry PE Ratio Median Figure of 66 Publicly-Listed Chemicals Companies 19.07x
United States of America Market PE Ratio Median Figure of 3,081 Publicly-Listed Companies 18.18x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Uralkali.

OTCPK:URAY.Y PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= MISX:URKA Share Price ÷ EPS (both in USD)

= 1.37 ÷ -0.08

-18.08x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Uralkali is loss making, we can't compare its value to the US Chemicals industry average.
  • Uralkali is loss making, we can't compare the value of its earnings to the United States of America market.
Price based on expected Growth
Does Uralkali's expected growth come at a high price?
Raw Data
OTCPK:URAY.Y PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -18.08x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
23.4%per year
United States of America Chemicals Industry PEG Ratio Median Figure of 46 Publicly-Listed Chemicals Companies 1.56x
United States of America Market PEG Ratio Median Figure of 2,109 Publicly-Listed Companies 1.56x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Uralkali, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Uralkali's assets?
Raw Data
OTCPK:URAY.Y PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-12-31) in USD $0.59
MISX:URKA Share Price * MISX (2019-04-12) in RUB RUB88.06
MISX:URKA Share Price converted to USD reporting currency Exchange rate (RUB/ USD) 0.016 $1.37
United States of America Chemicals Industry PB Ratio Median Figure of 91 Publicly-Listed Chemicals Companies 2.29x
United States of America Market PB Ratio Median Figure of 5,184 Publicly-Listed Companies 1.91x
OTCPK:URAY.Y PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= MISX:URKA Share Price ÷ Book Value per Share (both in USD)

= 1.37 ÷ 0.59

2.32x

* Primary Listing of Uralkali.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Uralkali is overvalued based on assets compared to the US Chemicals industry average.
X
Value checks
We assess Uralkali's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Chemicals industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Chemicals industry average (and greater than 0)? (1 check)
  5. Uralkali has a total score of 2/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

URAY.Y Future Performance

 How is Uralkali expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

  • No analysts cover Uralkali, future earnings growth has been estimated based on fundamentals.
The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
23.4%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Uralkali expected to grow at an attractive rate?
  • Uralkali's earnings growth is expected to exceed the low risk savings rate of 2.7%.
Growth vs Market Checks
  • Uralkali's earnings growth is expected to exceed the United States of America market average.
  • Unable to compare Uralkali's revenue growth to the United States of America market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
OTCPK:URAY.Y Future Growth Rates Data Sources
Data Point Source Value (per year)
OTCPK:URAY.Y Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts 23.4%
United States of America Chemicals Industry Earnings Growth Rate Market Cap Weighted Average 12.2%
United States of America Chemicals Industry Revenue Growth Rate Market Cap Weighted Average 2.2%
United States of America Market Earnings Growth Rate Market Cap Weighted Average 13.4%
United States of America Market Revenue Growth Rate Market Cap Weighted Average 7%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
OTCPK:URAY.Y Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
OTCPK:URAY.Y Future Estimates Data
Date (Data in USD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
OTCPK:URAY.Y Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2018-12-31 2,754 1,096 -98
2018-09-30 2,762 1,075 163
2018-06-30 2,770 1,053 424
2018-03-31 2,765 882 649
2017-12-31 2,761 711 874
2017-09-30 2,676 802 909
2017-06-30 2,591 894 943
2017-03-31 2,435 953 1,185
2016-12-31 2,278 1,012 1,427
2016-09-30 2,457 1,160 995
2016-06-30 2,636 1,308 562
2016-03-31 2,880 1,544 372

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Uralkali's earnings are expected to grow significantly at over 20% yearly.
  • Unable to determine if Uralkali is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
OTCPK:URAY.Y Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from Uralkali Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

OTCPK:URAY.Y Future Estimates Data
Date (Data in USD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
OTCPK:URAY.Y Past Financials Data
Date (Data in USD Millions) EPS *
2018-12-31 -0.08
2018-09-30 0.13
2018-06-30 0.32
2018-03-31 0.49
2017-12-31 0.65
2017-09-30 0.68
2017-06-30 0.70
2017-03-31 0.86
2016-12-31 1.01
2016-09-30 0.64
2016-06-30 0.33
2016-03-31 0.19

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Uralkali will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
X
Future performance checks
We assess Uralkali's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United States of America market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United States of America market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Uralkali has a total score of 3/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

URAY.Y Past Performance

  How has Uralkali performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Uralkali's growth in the last year to its industry (Chemicals).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Uralkali does not make a profit even though their year on year earnings growth rate was positive over the past 5 years.
  • Unable to compare Uralkali's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Uralkali's 1-year growth to the US Chemicals industry average as it is not currently profitable.
Earnings and Revenue History
Uralkali's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Uralkali Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

OTCPK:URAY.Y Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-12-31 2,753.58 -97.64 774.22
2018-09-30 2,761.69 163.26 813.81
2018-06-30 2,769.81 424.16 853.39
2018-03-31 2,765.34 649.07 861.76
2017-12-31 2,760.87 873.98 870.14
2017-09-30 2,676.00 908.67 833.46
2017-06-30 2,591.13 943.36 796.79
2017-03-31 2,434.69 1,185.32 735.22
2016-12-31 2,278.25 1,427.28 673.64
2016-09-30 2,457.01 994.74 660.67
2016-06-30 2,635.77 562.20 647.70
2016-03-31 2,879.54 371.72 686.68
2015-12-31 3,123.30 181.24 725.65
2015-09-30 3,259.46 -129.44 829.08
2015-06-30 3,395.63 -440.11 932.52
2015-03-31 3,477.46 -533.71 1,037.38
2014-12-31 3,559.29 -627.31 1,142.24
2014-09-30 3,496.79 4.26 1,196.45
2014-06-30 3,434.28 635.82 1,250.66
2014-03-31 3,378.45 651.34 1,177.43
2013-12-31 3,322.62 666.86 1,104.20
2013-09-30 3,326.09 912.03 1,001.29
2013-06-30 3,329.57 1,157.21 898.39
2013-03-31 3,639.68 1,379.01 920.58
2012-12-31 3,949.79 1,600.81 942.78
2012-09-30 4,207.19 1,587.17 961.32
2012-06-30 4,464.58 1,573.53 979.86

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Uralkali has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • Uralkali used its assets less efficiently than the US Chemicals industry average last year based on Return on Assets.
  • It is difficult to establish if Uralkali improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Uralkali's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Chemicals industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Uralkali has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

URAY.Y Health

 How is Uralkali's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Uralkali's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Uralkali's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
  • Uralkali's long term commitments exceed its cash and other short term assets.
Balance sheet
This treemap shows a more detailed breakdown of Uralkali's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is not covered by short term assets, assets are 0.3x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Uralkali Company Filings, last reported 3 months ago.

OTCPK:URAY.Y Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2018-12-31 770.47 6,028.54 1,043.29
2018-09-30 770.47 6,028.54 1,043.29
2018-06-30 988.98 6,137.34 865.87
2018-03-31 988.98 6,137.34 865.87
2017-12-31 1,149.56 6,565.16 1,091.32
2017-09-30 1,149.56 6,565.16 1,091.32
2017-06-30 725.26 7,119.30 1,398.33
2017-03-31 725.26 7,119.30 1,398.33
2016-12-31 276.08 7,279.91 1,553.79
2016-09-30 276.08 7,279.91 1,553.79
2016-06-30 24.55 7,755.39 1,557.95
2016-03-31 24.55 7,755.39 1,557.95
2015-12-31 -613.03 7,074.94 1,179.48
2015-09-30 -613.03 7,074.94 1,179.48
2015-06-30 2,302.31 6,538.03 2,572.78
2015-03-31 2,302.31 6,538.03 2,572.78
2014-12-31 2,670.84 6,198.53 2,516.46
2014-09-30 2,670.84 6,198.53 2,516.46
2014-06-30 5,845.32 4,845.94 809.56
2014-03-31 5,845.32 4,845.94 809.56
2013-12-31 5,741.61 5,179.84 930.17
2013-09-30 5,741.61 5,179.84 930.17
2013-06-30 7,237.90 4,106.37 1,262.09
2013-03-31 7,237.90 4,106.37 1,262.09
2012-12-31 8,758.39 3,973.81 1,658.37
2012-09-30 8,758.39 3,973.81 1,658.37
2012-06-30 7,824.77 4,056.89 1,600.59
  • Uralkali's level of debt (782.5%) compared to net worth is high (greater than 40%).
  • The level of debt compared to net worth has increased over the past 5 years (90.1% vs 782.5% today).
  • Debt is not well covered by operating cash flow (18.2%, less than 20% of total debt).
  • Uralkali is making a loss, therefore interest payments are not well covered by earnings.
X
Financial health checks
We assess Uralkali's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Uralkali has a total score of 0/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

URAY.Y Dividends

 What is Uralkali's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Uralkali dividends.
If you bought $2,000 of Uralkali shares you are expected to receive $0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Uralkali's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Uralkali's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
OTCPK:URAY.Y Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
United States of America Chemicals Industry Average Dividend Yield Market Cap Weighted Average of 55 Stocks 2.5%
United States of America Market Average Dividend Yield Market Cap Weighted Average of 2009 Stocks 2.4%
United States of America Minimum Threshold Dividend Yield 10th Percentile 0.8%
United States of America Bottom 25% Dividend Yield 25th Percentile 1.4%
United States of America Top 25% Dividend Yield 75th Percentile 3.6%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

OTCPK:URAY.Y Future Dividends Estimate Data
Date (Data in $) Dividend per Share (annual) Avg. No. Analysts
OTCPK:URAY.Y Past Annualized Dividends Data
Date (Data in $) Dividend per share (annual) Avg. Yield (%)
2016-04-11 0.000 0.000
2015-09-21 0.000 0.000
2015-08-25 0.000 0.000
2015-03-05 0.000 0.000
2015-01-15 0.000 0.000
2014-12-26 0.000 0.000
2014-08-28 0.100 3.220
2013-12-18 0.188 4.140
2013-09-10 0.270 5.111
2013-04-10 0.270 4.381
2012-12-12 0.270 3.547
2012-09-12 0.240 3.058
2012-04-11 0.240 3.162
2011-09-22 0.260 3.430
2011-04-01 0.160 1.831
2010-09-03 0.054 0.929
2010-03-01 0.053 1.378
2010-02-10 0.000 0.000

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Uralkali has not reported any payouts.
  • Unable to verify if Uralkali's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Uralkali's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Uralkali has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Uralkali's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Uralkali afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Uralkali has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

URAY.Y Management

 What is the CEO of Uralkali's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Dmitry Osipov
AGE 52
TENURE AS CEO 5.3 years
CEO Bio

Mr. Dmitry Vasilievich Osipov has been the Chief Executive Officer and General Director of Public Joint Stock Company Uralkali since January 2014 and since December 24, 2013 respectively. Mr. Osipov has been Chairman of the Management Board at Public Joint Stock Company Uralkali since December 2013. Mr. Osipov served as General Manager of Kirovo-Chepetsk Chemical Enterprise named after Konstantinov. From 2007 to 2011, he served as Chief Executive Officer of URALCHEM Holding PLC. From 2005 and 2007, he served as the Chief Executive Officer of Kirovo-Chepetsk Chemical Plant OJSC. Mr. Osipov served as the Chief Executive Officer of Open Joint Stock Company United Chemical Company Uralchem from 2007 to January 25, 2011. He served as Chief Executive Officer of KCCW OJSC, a subsidiary of URALCHEM from 2005 to 2007. He served as the Deputy Chairman of the Board of Open Joint Stock Company United Chemical Company Uralchem since January 25, 2011 until 2013. Mr. Osipov has been a Director of Open Joint Stock Company United Chemical Company Uralchem since July 7, 2016. Mr. Osipov has been a Director of Azot Cherkassy Joint Stock Co. since July 2009. He has been a Director at OAO Voskresensk Mineral Fertilizers since September 2008. He served as a Member of the Board of Directors at Open Joint Stock Company United Chemical Company Uralchem since 2007 until 2013. He served as a Director of Kirovo-Chepetsk Chemical Enterprise named after Konstantinov. From the middle 1990's, he served the top management positions in large chemical companies: Khimprom (Volgograd), Propan-Butanovaya Company, Sibur-Khimprom from 2005 to 2007. He has been Director of Public Joint Stock Company Uralkali since June 2014. He has been Member of the Commission for the Mineral Fertiliser Production and Market of the Russian Union of Industrialists and Entrepreneurs. Since 2011, he has been the Member of the Council and Financial Committee of International Fertilizer Association (IFA). Mr. Osipov is a Graduate of Gorkiy State University (Radiophysics and Cybernetics Department) and Graduated from Lobachevsky State University of Nizhny Novgorod.

CEO Compensation
  • Insufficient data for Dmitry to compare compensation growth.
  • Insufficient data for Dmitry to establish whether their remuneration is reasonable compared to companies of similar size in United States of America.
Management Team Tenure

Average tenure and age of the Uralkali management team in years:

4.3
Average Tenure
47
Average Age
  • The tenure for the Uralkali management team is about average.
Management Team

Dmitry Osipov

TITLE
CEO, Chairman of the Management Board & Director
AGE
52
TENURE
5.3 yrs

Anton Vishanenko

TITLE
CFO & Member of Management Board
AGE
39
TENURE
4.5 yrs

Marina Shvetsova

TITLE
Director of Legal & Corporate Affairs and Member of Management Board
AGE
46
TENURE
14.3 yrs

Vitaly Lauk

TITLE
Technical Director & Member of Management Board
AGE
50
TENURE
4.3 yrs

Irina Konstantinova

TITLE
Director of Human Resource & Member of Management Board
AGE
40
TENURE
2.3 yrs

Aleksandra Orlova

TITLE
Chief Accountant and Member of Audit Commission

Angelina Verba

TITLE
Head of Investor Relations & Capital Markets

Andrey Sidorov

TITLE
Head of Public Relations
AGE
47

Yevgeny Kotlyar

TITLE
Head of EuroChem Ore Mining Division
AGE
60
TENURE
1.3 yrs

Anton Bazulev

TITLE
Head of Government Relations
TENURE
3 yrs
Board of Directors Tenure

Average tenure and age of the Uralkali board of directors in years:

2.7
Average Tenure
52
Average Age
  • The average tenure for the Uralkali board of directors is less than 3 years, this suggests a new board.
Board of Directors

Sergey Chemezov

TITLE
Chairman of the Board
AGE
66
TENURE
5.1 yrs

Dmitry Osipov

TITLE
CEO, Chairman of the Management Board & Director
AGE
52
TENURE
5.1 yrs

Dmitry Mazepin

TITLE
Deputy Chairman of the Board
AGE
50
TENURE
5.1 yrs

Dmitry Lobyak

TITLE
Deputy Chairman of the Board
AGE
51
TENURE
1.3 yrs

Aleksandra Orlova

TITLE
Chief Accountant and Member of Audit Commission

Paul Ostling

TITLE
Senior Independent Director
COMPENSATION
$14M
AGE
70
TENURE
1.3 yrs

Luc Maene

TITLE
Independent Director
AGE
72
TENURE
2.8 yrs

Dimitry Tatyanin

TITLE
Non-Executive Director
AGE
51
TENURE
2.6 yrs

Daniel Wolfe

TITLE
Independent Director
AGE
53
TENURE
0.8 yrs

Igor Bulantsev

TITLE
Non-Executive Director
AGE
49
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price ($) Value ($)
X
Management checks
We assess Uralkali's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Uralkali has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

URAY.Y News

Simply Wall St News

URAY.Y Company Info

Description

Public Joint Stock Company Uralkali, together with its subsidiaries, engages in the extraction, production, and sale of potash fertilizers. It holds operating licenses for the extraction of potassium, magnesium, and sodium salts from the Durimanskiy, Bigelsko-Troitsky, Solikamskiy, Novo-Solikamskiy, and Romanovskoye plots of the Verkhnekamskoye field. The company also owns a license for the Ust'-Yaivinskiy plot and the Polovodovskiy plot of the Verkhnekamskoye field. It produces standard and granular muriate of potash; and carnallite and sodium chloride. In addition, the company provides construction, repair and maintenance, transportation, sea terminal, scientific institute, and trading services. It has operations in Russia, China, India, Southeast Asia, Latin America, the United States, Europe, and other countries. The company was founded in 1930 and is based in Berezniki, Russia.

Details
Name: Public Joint Stock Company Uralkali
URAY.Y
Exchange: OTCPK
Founded: 1930
RUB1,754,593,678
1,276,165,037
Website: http://www.uralkali.com
Address: Public Joint Stock Company Uralkali
63 Pyatiletki Street,
Berezniki,
Permskaya obl., 618426,
Russia
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
MISX URKA Ordinary Shares Micex - Rts RU RUB 28. Jan 2003
OTCPK URAY.Y GDR EACH REPR 5 ORD 'REGS' Pink Sheets LLC US USD 15. Oct 2007
Number of employees
Current staff
Staff numbers
0
Uralkali employees.
Industry
Fertilizers and Agricultural Chemicals
Materials
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/04/22 00:09
End of day share price update: 2019/04/12 00:00
Last estimates confirmation: 2018/04/03
Last earnings filing: 2019/03/16
Last earnings reported: 2018/12/31
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.